Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
10.51
+0.44 (4.37%)
At close: Aug 4, 2026, 4:00 PM EDT
10.40
-0.11 (-1.05%)
Pre-market: Aug 5, 2026, 4:32 AM EDT
Candel Therapeutics Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Candel Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $20.5. The average 1-year stock price forecast is 95.05% higher than the current stock price, while the lowest is $9.00 (-14.37%) and the highest is $29 (+175.93%).
Price Target: $20.5 (+95.05%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Candel Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 8 | 7 | 8 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 9 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $23 | Buy | Maintains | $23 | +118.84% | Jul 29, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Initiates $22 | Buy | Initiates | $22 | +109.32% | Jul 13, 2026 |
| Citi | Citi | Buy Maintains $26 | Buy | Maintains | $26 | +147.38% | Jun 30, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $9 | Hold | Maintains | $9 | -14.37% | Jun 1, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $25 | Buy | Maintains | $25 | +137.87% | May 18, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
42.84M
EPS This Year
-0.90
from -0.88
EPS Next Year
-0.61
from -0.90
EPS and Forward PE are based on non-GAAP adjusted numbers.